baber/WOPTO huggingface dataset:
Patent NO-871269-D0 (NO)
Inventor: FREI JOSEF
IPC: B07B9/00
Filed: 1987-03-26
Abstract: A process for working up household, industrial and other similar waste for the recovery of a fibrous and/or granulated material, in which the waste material is subjected to preliminary comminution, magnetic separation, classification, drying and fractionation, wherein the light fraction resulting from the classification carried out after the magnetic separation is subjected to secondary comminution by cutting, and the heavy fraction to a predominantly granulating secondary comminution and thereafter both comminution products are recombined, dried and fractionated into fibrous matter and granulated material, is to be simplified, and in particular the costs reduced. This is achieved in that before the secondary cutting comminution appliance at least one part stream or the whole stream of the light fraction is diverted and fed directly and/or after comminution in a further comminution unit to further utlization. A device for carrying out the method is also proposed.
Patent NO-890573-D0 (NO)
Inventor: GIUSTI GIAMBATTISTA
IPC: B01D46/42
Filed: 1989-02-10
Abstract: An industrial dust collecting apparatus such as a fabric type gas filter includes at least one velocity reducing transition section 70 employing a selectively positioned expanded metal grid 76 as a flow diverting and gas stream diffusing device located at the exit port 74 thereof.
Patent NO-901579-D0 (NO)
Inventor: ALLGEIER HANS
IPC: C07F9/38
Filed: 1990-04-06
Abstract: Unsaturated aminodicarboxylic acid derivatives of formula (I) <IMAGE> in which A represents a divalent aliphatic hydrocarbon radical with 2 carbon atoms and R1 and R2 independently of each other represent free or esterified carboxyl groups, and their salts possess an outstanding and selective antagonistic effect on excitatorial amino acid receptors sensitive to N-methyl-D-aspartic acid. They are prepared for example by converting Z3 in a compound of formula II <IMAGE> in which Z1 and Z2 stand for optionally protected hydroxyl and Z3 represents protected amino, into amino and, if present, protected hydroxyl Z1 and/or Z2 into hydroxy, and if desired converting one compound obtained into another compound of formula I, an isomeric mixture obtainable using this method being separated into the components and the particular preferred isomer being separated out and/or a free compound obtainable using this method being converted into a salt or a salt obtainable using this method being converted into the free compound.
Patent NO-903025-D0 (NO)
Inventor: CAPPELLO JOSEPH
IPC: C07K19/00
Filed: 1990-07-06
Abstract: Novel polymers are provided which are produced by recombinant techniques. The polymers are characterized by having a small repeating sequence which provides for strands capable of associating, resulting in useful structural characteristics, where the strands are joined by turns or loops which are flexible and available for interaction with the environment. Specifically, repeating groups of naturally occurring proteins such as silk are modified by introduction of an amino-acid sequence at a site which provides for a turn between strands to provide for readily available oligopeptides capable of interacting with molecules in the environment.
Patent NO-904169-D0 (NO)
Inventor: ANGST CHRISTOF
IPC: A61K31/685
Filed: 1990-09-25
Abstract: Substituted 2-aminoalk-3-enoic acid derivatives of the formula I <IMAGE> process for the preparation of unsaturated amino carboxylic acid derivatives of the formula I <IMAGE> in which R1 is an aliphatic or via a C atom bonded oxacycloaliphatic or optionally aliphatically N-substituted or N-acylated azacycloaliphatic hydrocarbon radical which is substituted by optionally acylated or aliphatically or araliphatically etherified hydroxyl, by halogen, by optionally acylated and/or aliphatically substituted amino or by an aza-, diaza-, azoxa- or oxacycloaliphatic radical, and R2 is free or esterified carboxyl, and their salts have a pronounced and selective antagonistic action on N-methyl-D-aspartic acid-sensitive (NMDA-sensitive) excitatory amino-acid receptors. They are prepared, for example, by, in a compound of the formula II <IMAGE> in which Z1, Z2 are optionally protected hydroxyl, Z3 is an aliphatic or via a C atom bonded oxacycloaliphatic or optionally protected or aliphatically N-substituted or N-acylated azacycloaliphatic hydrocarbon radical which is substituted by optionally protected or acylated or aliphatically or araliphatically etherified hydroxyl, by halogen, by optionally protected or acylated and/or aliphatically substituted amino or by an aza-, diaza-, azoxa- or oxacycloaliphatic radical, and Z4 is protected amino, converting protected amino Z4 and, where present, as component of Z3 into amino and, where present, protected hydroxyl Z1, Z2 and/or as component of Z3 into hydroxyl, and, where present, liberating a protected azacycloaliphatic hydrocarbon radical Z3 and, if required, converting a resulting compound into another compound of the formula I, fractionating a mixture of isomers obtainable according to the process into the components, and separating off the isomer which is preferred in each case, and/or converting a free compound obtainable according to the process into a salt or a salt obtainable according to the process into the corresponding free compound.
Patent NO-910904-D0 (NO)
Inventor: SHIOKAWA YOUICHI
IPC: C07C211/00
Filed: 1991-03-07
Abstract: The invention relates to a substituted-amine compound of the following formula: <CHEM> pharmaceutical acceptable salts of it, processes for preparing it, pharmaceutical compositions comprising it and its use for the manufacture of medicaments.
Patent NO-912030-D0 (NO)
Inventor: HEIKKILAE HEIKKI
IPC: A23L27/30
Filed: 1991-05-27
Abstract: A crystalline lactitol monohydrate having lattice cell constants a = 7.815 +/- 0.008  ANGSTROM , b = 12.682 +/- 0.008  ANGSTROM , and c = 15.927 +/- 0.008  ANGSTROM , and a melting range between 90 and 105 DEG C, and a water content between 4.85 and 5.15%, as well as a process of preparing said crystalline lactitol monohydrate by evaporating the aqueous solution of lactitol to a concentration between 75 and 88% by weight, cooling the resultant mixture at a temperature ranging between 30 and 75 DEG C, subsequently separating the lactitol monohydrate crystals from the mother liquor, and subsequently drying with air having a temperature between 120 DEG C, and a relative humidity between 0 and 40 %, for a time period less than 24 hours. The invention also relates to the use of said crystalline lactitol monohydrate as a bulk sweetener for the total or partial replacement of sucrose in dietetic products, confectionery, bakery products, cereals, desserts, jams, beverages, chocolate, chewing-gum and ice-cream, and in pharmaceuticals and cosmetic products, such as tooth paste, as well as a special sweetening agent resembling sucrose, mainly composed of said crystalline lactitol monohydrate.
Patent NO-921865-D0 (NO)
Inventor: MERLO GIUSEPPE
IPC: B65F3/00
Filed: 1992-05-12
Abstract: The vehicle includes a body (2) which has an opening (12) at its rear and contains a pair of superposed longitudinal guides (14, 16) along which a plate (20) can slide to discharge the refuse. The movable plate (20) carries a first pair of rollers (24) which run along the first guide (14) and two pairs of rollers (26) which run along the second guide (16). The second rollers (26) are disengaged from the second guide (16) when the first rollers (24) contact a stop (28) at the rear end of the first guide (14). The further operation of the actuator (32) which moves the plate thus causes the plate (20) to pivot about a transverse axis which passes through the end-of-travel position of the first rollers (24). <IMAGE>
Patent NO-922379-D0 (NO)
Inventor: GRAHN EVA ELISABETH
IPC: A61K35/74
Filed: 1992-06-17
Abstract: PCT No. PCT/SE90/00850 Sec. 371 Date Jun. 16, 1992 Sec. 102(e) Date Jun. 16, 1992 PCT Filed Dec. 19, 1990 PCT Pub. No. WO91/09608 PCT Pub. Date Jul. 11, 1991.A pharmaceutical preparation for controlling pathogenic microorganisms causing diarrhoea and other gastrointestinal troubles in man and in animals contains Streptococcus lactis strain LIa in at least one pharmaceutically acceptable carrier medium in which the microorganism retains its viability. The use of the preparation for controlling pathogenic microorganisms causing diarrhoea and other gastrointestinal infections in man and in animals is also described.
Patent NO-924646-D0 (NO)
Inventor: AXELSSON OSKAR
IPC: A61P25/28
Filed: 1992-12-02
Abstract: The present invention discloses compounds of the formula <CHEM>  wherein R' and R'' independently of each other are hydrogen or alkyl, or R' and R'' together form a 3 to 6 membered alkylene chain;  n is 1 or 2; R<1> is phenyl which may be substituted one or more times with halogen, CF3, alkoxy, alkyl, or amino; and R<4>, R<5>, R<6> and R<7> independently of each other are hydrogen, halogen, amino, CF3, alkyl or alkoxy; or a pharmaceutically-acceptable addition salt thereof. The compounds are useful as pharmaceuticals, for example, in the treatment of ischemia, anoxia, migraine and psychosis.
Patent NO-931976-D0 (NO)
Inventor: SCHOEPS MICHAEL
IPC: D04H3/10
Filed: 1993-05-28
Abstract: There are described a dimensionally stable laminate (layered product, sheet) whose surfaces are formed by spunbonded webs (non-woven, spun-bondeds, spunbonds) and which consists of at least two layers of spun-bonded and at least one laid layer (scrim, network) of reinforcing yarn, the laid layer or layers each being disposed between two layers of spunbonded and having a thread density from 0.5 to 3 threads/cm, the spunbonded and laid layers having been joined together by needling at about 20 - 70 stitches/cm<2>; a process for manufacturing this laminate; and its use for manufacturing roofing felts and underfelts (sarking, underslating). <IMAGE>
Patent NO-932020-D0 (NO)
Inventor: SCHULZE JOACHIM
IPC: C04B24/32
Filed: 1993-06-03
Abstract: The subject of the invention is the use of polypropylene glycol as an additive reducing the amount of shrinkage in dispersion powder compositions for building materials, containing   a) a base polymer from the group comprising the vinyl ester polymers, (meth)acrylate and/or styrene (co)polymers and vinyl chloride polymers and   b) either   b1) 2 to 20 % by weight, relative to the base polymer, of polyvinyl alcohol with a degree of hydrolysis of 85 to 94 mol % and a Höppler viscosity of from 2 to 40 mPa.s or b2) 2 to 20 % by weight, relative to the base polymer, of alkali metal salts or alkaline earth metal salts of phenolsulphonic acid/formaldehyde condensation products, and also   c) 3 to 30 % by weight, relative to the total weight of polymeric constituents, of a fine antiblocking agent, characterised in that d) 1 to 20 % by weight, relative to the base polymer, of polypropylene glycol is present.   The dispersion powder composition is particularly suitable for use in building materials, in particular dry mortars, which contain Portland cement as inorganic binder, and leads therein to lower shrinkage of the mortars.
Patent NO-932798-D0 (NO)
Inventor: VERNONDIER DAVID RICHARD
IPC: F21V23/00
Filed: 1993-08-05
Abstract: A lighting system includes a plurality of modular components, comprising elongate strips (65) of different finite lengths having elongate lighting circuits (67-69) therein and connector means (110) for connecting adjacent strips (65) end to end and electrically conecting the lighting circuits (67-69) thereon to enable a voltage to be applied across a series of illuminating devices (60, 60') provided at predetermined spaced locations along the length of the strips (65) so connected. The illuminating devices on each strip are connected in series and the series connected illuminating devices associated with each strip are connected in parallel with the series connected illuminating devices associated with each of the other strips. The series connections of the illuminating devices associated with the respective strips are balanced so that they are voltage compatible with one another. In some embodiments a plurality of series connected illuminating devices are provided on each strip. Ring voltage supply lines (200, 201) and voltage pulse control (202) lines may also be provided on the strips (65).
Patent NO-933942-D0 (NO)
Inventor: COHEN IRUN R
IPC: A61K31/727
Filed: 1993-11-01
Abstract: The present invention relates to methods for the prevention and/or treatment of pathological processes involving the induction of TNF- alpha  secretion comprising a pharmaceutically acceptable carrier and a low molecular weight heparin (LMWH). In the pharmaceutical compositions of the present invention, the LMWH is present in a low effective dose and is administered at intervals of about 5-8 days. Furthermore, the LMWH is capable of inhibiting in vitro TNF- alpha  secretion by resting T cells and/or macrophages in response to T cell-specific antigens, mitogens, macrophage activators, disrupted extracellular matrix (dECM), laminin, fibronectin, and the like.
Patent NO-942903-D0 (NO)
IPC: A61P11/06
Filed: 1994-08-04
Abstract: Amidine derivs. of formula (I), in the form of their racemates, enantiomer pure or enriched forms, diastereomer pairs, cis- and trans-isomers, free bases or salts (pref. with physiologically acceptable acids) are new. In (I), R1 and R2 are each CF3, halogen, R5, OR5, COR6, SR6, SOR6, SO2R6, SO2NR5R7, C(OH)R5R7, or R1 and R2 connect neighbouring C atoms on the benzene ring to which they are attached with -CR8=CR9CH=CH-, -CH=CR8CR9=CH-, -CR8=CHCR9=CH-, -OCHR10CH2-, -OCH2O-, -OCH2CH2O-, -(CH2)3-4-, -NHCOO-, -NHCOCH2O-, -COCH2O- or -COCH2CH2O-, each of these gps. being opt. substd. with 1-4C alkyl; R3 is H, OH, CF3, R5, OR6, COR6, CONR5R7, CH2OH, CH2O(1-4C alkyl), SR6, SOR6, SO2R6, SO2NR5R7, NHCO(1-4C alkyl), NHSO2(1-4C alkyl), NR5R7 or C(OH)R5R7 or a heterocyclic 5-ring contg. 1-3 heteroatoms and of formulae (a), (b) or (c); provided that if R3 is R5, R5 can only be H if at least one of R1 and R2 is not H; D, E and G are each CH, N, C(1-4C alkyl) or C-Ph; L is O or S; R4 is halogen, NH2, NH(1-4C alkyl), N(1-4C alkyl)2, OH, 1-4C alkoxy; R5 is H, 1-12C alkyl, phenyl(1-4C)alkyl or Ph (opt. substd. with halogen, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl); R6 is 1-12C alkyl, Ph (opt. substd. with halogen, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl); R7 is H or 1-12C alkyl; R8 and R9 are each H, OH, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl; R10 is H or 1-4C alkyl; R11 and R12 are each H, OH, halogen, CF3, 1-4C alkyl or 1-4C alkoxy; A is (d), (e), X1A1X2, X2A2X3, X4A2X2, (CH2)1-2NHCO(CH2)1-3X2, -CH=CHA2X2; B is CH=CH, CH=N, S or (f); A1 is 2-4C alkylene, cis- or trans-CH2CH=CHCH2, CH2CCCH2, etc.; A2 is 1-5C alkylene; X1 is O, NH, S, SO, SO2, CO, CH2 or a gp. of formula (d); X2 is O, NH, S or a gp. of formula (e); X3 is NHCO, CONH, SO2NH or a gp. of formula (d); X4 is NHCO, CONH, NHSO2, SO2NH or NHCONH.
Patent NO-943163-D0 (NO)
Inventor: TOBEY STEPHEN W
IPC: A23L29/20
Filed: 1994-08-26
Abstract: The present invention is directed to a baked food composition comprising food ingredients and a water-soluble cellulose ether which is useful for reducing the low-density lipoprotein serum cholesterol level of an animal. Use of a specific particle-size distribution of the water-soluble cellulose ether results in compositions which are more palatable than known compositions.
Patent NO-952315-D0 (NO)
Inventor: BILBIE CLIVE JAMES FRANK
IPC: G11B23/40
Filed: 1995-06-13
Abstract: PCT No. PCT/NZ93/00125 Sec. 371 Date Jun. 15, 1995 Sec. 102(e) Date Jun. 15, 1995 PCT Filed Dec. 15, 1993 PCT Pub. No. WO94/14148 PCT Pub. Date Jun. 23, 1994An erasable product such as a rewritable label, sign or the like includes a base layer and an upper sheet extending over the base layer. The upper sheet and the base layer are releasably adhesive together under pressure manually applied on the upper sheet to cause the base layer and upper sheet to adhere in a localized region of pressure in order to display writing, an indicia, or the like. A wipe-start region is provided where the base layer and the upper sheet are not adhesive together and in which a user may place a finger or thumb to wipe across the top surface of the upper sheet in order to separate the upper sheet from the base layer and erase the indicia.
Patent NO-960002-D0 (NO)
Inventor: PHAN DEAN VAN
IPC: D21H11/00
Filed: 1996-01-02
Abstract: Multi-layered tissue paper webs comprising biodegradable chemical softener compositions and binder materials are disclosed. The multi-layered tissue webs are useful in the manufacture of soft, absorbent paper products such as facial tissues and/or toilet tissues. The multi-layered tissue paper products contain a biodegradable chemical softening composition, preferably comprising a mixture of an ester-functional quaternary ammonium compound and a polyhydroxy compound. Preferred ester-functional quaternary ammonium compounds include diester dialkyl dimethyl ammonium salts such as diester di(touch hardened)tallow dimethyl ammonium chloride, diester di(hydrogenated)tallow dimethyl ammonium chloride. Preferred polyhydroxy compounds are selected from the group consisting of glycerol, sorbitols, polyglycerols having a weight average molecular weight of from about 150 to about 800, polyoxyethylene glycols and polyoxypropylene glycols having a weight average molecular weight from about 200 to 4,000. The multi-layered tissue paper webs also contain an effective amount of binder materials to control linting and/or to offset the loss in tensile strength, if any, resulting from the use of the chemical softening compositions. The binder materials are selected from the various wet and dry strength additives, and retention aids used in the paper making art. Preferably, the majority of the biodegradable chemical softening compositions will be disposed on the outer layers of the multi-layered tissue paper products where they are most effective. The binder materials are typically dispersed throughout the multi-layered product to control linting. In other words, the chemical softening compositions and the binder materials can be selectively distributed within the multi-layered tissue paper web to enhance the softness, absorbency, and/or lint resistance of a particular layer or ply.
Patent NO-960651-D0 (NO)
Inventor: KNEPP VICTORIA M
IPC: A61K9/08
Filed: 1996-02-19
Abstract: Aqueous formulations of nerve growth factor suitable for lyophilization and subsequent reconstitution in which nerve growth factor is admixed with sugars and buffer are provided.
Patent NO-973732-D0 (NO)
Inventor: MORALES ALVARO
IPC: C08B37/08
Filed: 1997-08-13
Abstract: A method of treating interstitial cystitis comprising contacting the transitional epithelium lining the urinary bladder and associated structures in a mammal having interstitial cystitis with a solution containing hyaluronic acid having a average molecular weight of not less than 2x105 Daltons in a concentration effective to treat the interstitial cystitis.
Patent NO-991354-D0 (NO)
Inventor: KOWITZ CHRISTOPH
IPC: C08G18/76
Filed: 1999-03-19
Abstract: PCT No. PCT/EP97/04908 Sec. 371 Date Mar. 17, 1999 Sec. 102(e) Date Mar. 17, 1999 PCT Filed Sep. 19, 1997 PCT Pub. No. WO98/12242 PCT Pub. Date Mar. 20, 1998Biodegradable polyesters based on A) 95-99.99 mol % of at least one polyester A containing as monomeric building blocks of an acid component comprising a11) 20-95 mol % of at least one aliphatic or cycloaliphatic dicarboxylic acid or its ester-forming derivative and a12) 5-80 mol % of at least one aromatic dicarboxylic acid or its ester-forming derivative and  at least one dihydroxy compound or at least one amino alcohol or their mixtures, and B) 0.01-5 mol % of a mixture comprising mono-, bi-, tri-, tetra- and higher-nuclear isocyanurates or corresponding compounds containing two, three or four functional groups capable of reacting with the end groups of polyester A, or mixtures of the isocyanurates and the corresponding compounds, as well as molding compositions comprising said polyesters, their manufacture and their use in the manufacture of moldings, filsm, fibers and coatings.
Patent NO-994290-D0 (NO)
Inventor: KAMB CARL ALEXANDER
IPC: C12Q1/68
Filed: 1999-09-03
Abstract: Methods for identifying nucleic acid sequences that affect a cellular phenotype are disclosed. The method uses a reporter gene whose level of expression correlates with the phenotype in conjunction with a method or device for measuring the level of reporter expression. An expression library is introduced into the cells, and those cells exhibiting changes in reporter expression level are selected. Expression library inserts from the selected cells are isolated, thereby providing a sub-library enriched for sequences that affect the phenotype reflected by the reporter. Further rounds of sub-library introduction and cell selection may be carried out to provide additional enrichment. Sequences identified using this method may be used to ascertain the identity of additional molecules involved in generating the cellular phenotype.
Patent GB-0003539-D0 (GB)
Title: Method of securing a shoot bolt to a gearbox and a gearbox therefor
IPC: E05B17/00
Filed: 2000-02-16
Abstract: The invention is embodied by a cremone gearbox which drives two shoot bolts 32 (only one shown) to lock an openable panel such as a window or door. The gearbox has a part such as rack 24 with serrations 28 that can be engaged with complementary serrations 30 on the shoot bolt and also carries a sliding member 40 that can be moved by actuation of the gearbox to secure the cooperating parts together. On assembly of the lock actuation of handle 12 (Fig 1) causes bolt 60 to project from and then move longitudinally relative to the gearbox and thereby push sliding member 40 into its operative position as shown in Fig 4. Projection 56 (Figs 5, 7) can be provided on the sliding member which locates in indentation 52 in the inoperative position and indentation 54 in the operative position.
Patent GB-0024683-D0 (GB)
Title: Non-return device
IPC: E03C1/298
Filed: 1996-12-04
Abstract: A non-return device (10) comprises a flat silicone rubber tubing (50) defining a pair of walls (70, 90) which separate to admit fluid in a forward direction but remain together to block fluid flow in a reverse direction. A tubular body (30) surrounds the tubing (50) and comprises an off-set outlet (34) to provide an uninterrupted fluid flow surface for use in a non-vertical orientation. The tubing (50) is mounted on a cartridge (130) which moves axially within the tubular body and compresses the tubing against the tubular body to effect a seal when the device is mounted on an outlet. The tubing (50) provides good operational characteristics and sensitivity as a consequence of having a wall thickness which is 0.3% to 3% of its width.
Patent GB-0028183-D0 (GB)
Title: Fabricating structures
IPC: B29C69/00
Filed: 2000-11-17
Abstract: In one aspect the invention provides a friction welded component, and a method of manufacture for such a component, comprising a pair of upstanding tubular members (6,8) which are friction welded at their respective end cross-sections, in coaxial concentric relationship, to a surface of a thin walled member (4). A reinforcement means (10) is provided in the region between the tubular members such that loads acting on the tubular members are more evenly distributed to the thin walled member. The wall thickness of the thin walled member is substantially the same as or greater than the wall thickness of the tubular members The invention finds particular application in the fabrication of bosses to gas turbine aero-engine casings.